P3 Therapeutic (P3T) is a preclinical biotechnology company founded in 2024 in Croatia. Our goal is to improve treatment outcomes and the quality of life for patients by creating precise small-molecule drugs (SCM) aimed at resolving chronic inflammation in spondyloarthritis (SpA) and related immune-mediated inflammatory diseases (IMID). Biotech Generation: 2025.  Founders: Miroslav Harjaček, Dario Naletilić,…